Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat-labile enterotoxin A subunit is the enzymatically active component of the AB5-type toxin produced by *E. coli*. Upon delivery to host cells by the B subunit pentamer, the A subunit catalyzes ADP-ribosylation of the Gsα protein, locking adenylate cyclase in its active state. This produces a massive increase in intracellular cAMP, ultimately driving the chloride and water secretion that results in severe diarrhea. The A subunit also modulates host immune signaling and plays a role in pathogen adherence and immune evasion by altering epithelial cell responses. It is both a critical virulence factor and a target for vaccine/adjuvant intervention[2][4][5][6].
ADP-ribosylation of Gsα subunit of host adenylate cyclase, leading to constitutive activation and increased cAMP production. This results in electrolyte and water secretion from intestinal cells and diarrhea. It also causes suppression of host innate immunity and mucin alteration (immunomodulation).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat-labile enterotoxin A subunit (eltA).